This study is being conducted to assess the safety and efficacy of 3 concentrations of
BBI-4000 and vehicle (4 treatment arms), applied for the treatment of axillary hyperhidrosis.
Drug: BBI-4000 Concentration 1
Drug: BBI-4000 Concentration 2
Drug: BBI-4000 Concentration 3
Drug: Vehicle (Placebo)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03024255
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Male or female subject ≥ 18 years of age.
Diagnosis of primary axillary hyperhidrosis that meets the following criteria: (a) symptoms of hyperhydrosis for at least 6 months' duration, (b) HDSM-Ax of 3 - 4, (c) HDSS of 3 or 4 and (d) a minimum GSP of 50 mg is each axilla with a combined total of at least 150 mg.
The ability to understand and follow all study-related procedures including study drug administration.
Sexually active female of childbearing potential (FOCBP)* must agree to periodic pregnancy testing and use a medically acceptable method of contraception while receiving protocol-assigned product.
In the Investigators opinion, any skin or subcutaneous tissue conditions of the axilla(s).
Prior use of any prohibited medication(s) or procedure(s) within the specified timeframe for the treatment of axillary hyperhidrosis.
Anticholinergic agents used to treat conditions such as, but not limited to, hyperhidrosis, asthma, incontinence, gastrointestinal cramps, and muscular spasms by any route of administration.
Use of potent inhibitors of cytochrome P450 CYP3A and CYP2D6.
Use of any cholinergic drug (e.g. bethanechol) within 30 days.
Known cause of hyperhidrosis or known history of a condition that may cause hyperhidrosis (i.e., hyperhidrosis secondary to any known cause such hyperthyroidism, diabetes mellitus, medications, etc.).
Subjects with unstable diabetes mellitus or thyroid disease, history of renal or hepatic impairment, malignancy glaucoma, intestinal obstructive or motility disease, obstructive uropathy, myasthenia gravis, BPH, neurological or psychiatric conditions, Sjögren's or Sicca syndrome, or cardiac abnormalities that may alter or exacerbate sweat production by the use of anticholinergics in the investigator's opinion.
Subjects with known hypersensitivity to glycopyrrolate, anticholinergics, or any of the components of the topical formulation.
Subject is pregnant, lactating or is planning to become pregnant during the study.
History or presence of supraventricular tachycardia, ventricular arrhythmias, atrial fibrillation or atrial flutter.
All locations for NCT03024255
United States (1)
IHHS Call Center
Charleston, South Carolina, United States, 29492
View full eligibility
Tris trial is registered with FDA with number: NCT03024255. The sponsor of the trial is Brickell Biotech, Inc. and it is looking for 227 volunteers for the current phase.
Official trial title: A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 3 Concentrations of Topically Applied BBI-4000 (Sofpironium Bromide) Gel in Subjects With Axillary Hyperhidrosis
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.